Implantable hepatic arterial infusion device: Placement without laparotomy via an intercostal artery

Journal of the American College of Surgeons

Volumn 187, Issue 5, 1998, Pages 565-568

  Castaing, Denis ^a   Azoulay, Daniel ^a   Fecteau, Annie H ^a   Bismuth, Henri ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGRAPHY; ARTERY CATHETER; ARTICLE; CLINICAL ARTICLE; FLUOROSCOPY; HUMAN; INFUSION; LIVER METASTASIS; PRIORITY JOURNAL; SURGICAL ANATOMY; SURGICAL TECHNIQUE;

ADULT; AGED; ANGIOGRAPHY; ARTERIES; CATHETERIZATION, PERIPHERAL; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; HEPATIC ARTERY; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRALESIONAL; LIVER NEOPLASMS; MICROSURGERY; MIDDLE AGED; OMENTUM; RIBS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVAL RATE; THORACOTOMY;

EID: 0031791701     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(98)00212-9     Document Type: Article

References (23)

1. Chang AE, Schneider PD, Sugarbaker PH, et al. A prospective randomized trial of regional versus systemic continous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987;206:685-693.
2. Kemeny N, Daly J, Rachman B, et al. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 1987;107:459-465.
3. Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continous intravenous versus hepatic intraarterial floxiuridine in patients with colorectal cancer metastic to the liver: the Northern California Oncology Group trial. J Clin Oncol 1989;7:1646-1654.
4. Safi F, Bittner R, Roscher R, et al. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial. Cancer 1989;64:379-387.
5. Martin KJ, O'Connell MJ, Wieand HS, et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg 1990;125:1022-1027.
6. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992;10:1112-1118.
7. Matsumada T, Yamagishi H, Bong Jin M, et al. Laparotomy versus interventional radiological procedures for implantation of arterial infusion devices. Surg Today 1997;27:398-402.
8. Cohen AM, Wood WC, Greenfield A, et al. Transbrachial hepatic arterial chemotherapy using an implanted infusion pump. Dis Colon Rectum 1980;23:223-227.
9. Cohen AM, Greenfield A, Wood WC, et al. Treatment of hepatic metastases by transaxillary hepatic artery chemotherapy using an implanted pump. Cancer 1983;51:2013-2019.
10. Arai Y. The study of catheter placement into the hepatic artery via the left subclavian artery for hepatic infusion therapy. J Nagoya City Univ Med Assoc 1988;39:453-464.
11. Germer CT, Boese-Landgraf J, Alb recht D, et al. Der vollimplantierbare minimal-invasive Arteria hepatica-Katheter zur locoregionaren Chemotherapie nicht-resektabler Lebermetastasen bei Defekten von konventionell implantierten Therapiekathetern. Chirurg 1996;67:458-462.
12. Feliciotti F, Paganini A, Guerrieri M, et al. Laparoscopic intraarterial catheter implantation for regional chemotherapy of the liver metastasis. Surg Endosc 1996;10:449-452.
13. Clouse ME, Ahmed R, Ryan RB, et al. Complications of longterm transbrachial hepatic artery infusion chemotherapy. Am J Roentgen 1977;129:799-803.
14. Hohn DC, Stagg RJ, Price DG, Lewis BJ. Avoidance of gastroduodenal toxicity in patients receiving hepatic arterial 5-fluoro-2-deoxyuridine. J Clin Oncol 1985;3:1257-1260.
15. Hiatt JR, Gabbay J, Busuttil RW. Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg 1994;220:50-52.
16. Chuang VP, Wallace S. Hepatic arterial redistribution for intraarterial infusion of hepatic neoplasm. Radiology 1980;135:292-299.
17. Rayner AA, Kerlan RK, Stagg RJ, et al. Total hepatic arterial perfusion after occlusion of variant lobar vessels: implications for hepatic arterial chemotherapy. Surgery 1986;99:708-715.
18. Elias D, Lasser P, Rougier R A simplified surgical technical procedure for intra-arterial chemotherapy in secondary liver cancer. Experience in 50 patients. Eur J Surg Oncol 1987;13:441-448.
19. Doughty JC, Warren H, Anderson JH, et al. Response to regional chemotherapy in patients with variant hepatic arterial anatomy. Br J Surg 1996;83:652-653.
20. Curley SA, Chase JL, Roh MS, Hohn DC. Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices. Surgery 1993;114: 928-935.
21. Niederhuber JE: Surgical aspects of intrahepatic artery therapy. In: Velde CJH, Sugarbaker PH, eds. Liver cancer. Nijhoff 1985; Nederland: 179-194.
22. Martin JK, Michael JO, Harry SW Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastasis from colorectal cancer. Cancer 1990;125:1022-1027.
23. Oberfield RA, McCaffrey JA, Polio J, et al. Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary cancer. Cancer 1979;44:414-423.